Public health experts met in New York recently to discuss expanding access in developing nations to artemisinin-combination therapy (ACT), which offers one of the fastest and most effective cures for malaria, USA Today reports. Malaria parasites have become resistant to older drugs, but funding for the newer ACT remains a problem. ACT costs about $1.50 for a three-day course, compared with 10 cents for older drugs such as chloroquine and Fansidar. Many African governments can devote just $5 per person annually to public health.